Edibles: Keeping your Patients and Customers Safe
Speakers: Lara Pearson, Pat Schneider, Gavin Kogan Moderator: Mary L. Shapiro
Customers Safe Speakers : Lara Pearson, Pat Schneider, Gavin Kogan - - PowerPoint PPT Presentation
Edibles: Keeping your Patients and Customers Safe Speakers : Lara Pearson, Pat Schneider, Gavin Kogan Moderator : Mary L. Shapiro Speakers Lara Pearson, BrandGeek, Pat Schneider, Healthy Bizz Gavin Kogan, Attorney Founder lara@brandgeek.net
Edibles: Keeping your Patients and Customers Safe
Speakers: Lara Pearson, Pat Schneider, Gavin Kogan Moderator: Mary L. Shapiro
Lara Pearson, BrandGeek, Founder lara@brandgeek.net Pat Schneider, Healthy Bizz pat@healthybizz.com Gavin Kogan, Attorney gavinkogan@gmail.com
Pat Schneider is a General Management “C-suite” executive with solid P&L experience and expertise in turnarounds. She has a strong consumer products background in leading existing business units, opening new markets and launching products globally for organizations including: P&G, J&J, Bristol-Myers Squibb, Bayer, Herbalife, Metagenics, Twinlab and Nelson Bach. She is currently CEO of Healthy Bizz, a strategic consultancy providing guidance to start-ups in the areas of business strategy, marketing, new product development, regulatory and operations for clients in the natural food, nutritional and legal cannabis related market sectors. Pat is also an advisor to members of Canopy Boulder/San Francisco, a mentorship-driven seed-stage business accelerator for entrepreneurs in the legal marijuana industry. Pat holds a BS in Microbiology, MBA in Finance & Marketing, JD in Commercial Law and is a licensed attorney in California. Pat can be reached at Pat@HealthyBizz.com or 310-779-6695
When combining an edible food product with an ingredient that is classified as a Schedule 1 drug, which product category does the resulting infused edible belong?
Food Drug Dietary Supplement Label Claims Allowed Nutrient Content Disease or Condition Structure/Function General Health Nutrient Deficiency Example Contains 100 Calories Relieves Arthritis Pain Supports Healthy Joints Substantiation Required for Claims Support Not False & Misleading FDA-Approved Double-Blind Placebo Controlled Human Clinical Trials (2) Food use pre-1994 Scientific Evidence Not False & Misleading Facts Panel Nutrition Drug Supplement Time to Market 30 days 2-5+ years 30 days (Pre-Mktg) FDA Market Entry Requirements GRAS IND & NDA (RX) Monograph & GRASE (OTC) GRAS or NDI cGMP Standard (P & WH) Food Pharmaceutical Dietary Supplement Packaging Requirements* Tamper Evident Tamper Evident & CRC Tamper Evident & CRC FDA CFR 21 CFR 110 21 CFR 210 & 211 (Rx) 21 CFR 330 (OTC) 21 CFR 111
manufacturing processes and facilities.
regulations governing:
can not be less restrictive.
597.htm#4-1